Login to Your Account



Search

Search results

Pharma: Clinic roundup

Bayer HealthCare Pharmaceuticals Inc. , of Whippany, N.J., began enrollment in a trial studying Xofigo (radium Ra 223 dichloride) injection in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mil ...

BioWorld Today - Staff - 2014-04-03 00:00 - 0 comments - 0 attachments

Clinic roundup

Cardiocell LLC , of San Diego, received investigational new drug approval from the FDA for a phase IIa study using its allogeneic stem cell therapy to treat patients with chronic heart failure (CHF). (BioWorld-Today-2014-04-03) ...

BioWorld Today - Staff - 2014-04-03 00:00 - 0 comments - 0 attachments

Clinic roundup

Galectin Therapeutics Inc. , of Norcross, Ga., said results from the first cohort of its phase I trial showed that GR-MD-02 had an effect on biomarkers that suggests a therapeutic effect on fibrosis, inflammation and cellular injury. (BioWor ...

BioWorld Today - Staff - 2014-04-02 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Forest Laboratories Inc ., of New York, and Gedeon Richter Plc , of Budapest, Hungary, reported positive top-line results from a global, randomized, placebo-controlled, fixed-dose, eight-week phase IIb trial evaluating the efficacy and safety of c ...

BioWorld Today - Staff - 2014-04-01 00:00 - 0 comments - 0 attachments

Clinic roundup

Capricor Therapeutics Inc. , of Los Angeles, presented data at the American College of Cardiology 63rd Annual Scientific Session and Expo highlighting positive data from the phase I portion of the company’s ALLSTAR (ALLogeneic heart STem cells to Ach ...

BioWorld Today - Staff - 2014-04-01 00:00 - 0 comments - 0 attachments

Clinic roundup

Cytokinetics Inc. , of South San Francisco, said it began enrolling the expansion phase of COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure). The double-blind, randomized, placebo-controlled, multicente ...

BioWorld Today - Staff - 2014-03-31 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Pfizer Inc. , of New York, and Bristol-Myers Squibb Co. , also of New York, said results of a pre-specified subanalysis of the phase III ARISTOTLE trial assessing the effect of blood pressure control on outcomes as well as the treatment effect of ...

BioWorld Today - Staff - 2014-03-28 00:00 - 0 comments - 0 attachments

Clinic roundup

Bluebird Bio Inc. , of Cambridge, Mass., said the first subject with beta-thalassemia major was enrolled in its phase I/II Northstar Study (HGB-204) and has undergone infusion with the company’s Lentiglobin drug product in an autologous hematopoietic ...

BioWorld Today - Staff - 2014-03-28 00:00 - 0 comments - 0 attachments

Clinic Roundup

• TapImmune Inc. , of Seattle, said the Mayo Clinic received investigational new drug application allowance for a Phase I trial of the company's HER-2/neu vaccine in breast cancer patients who finished standard Herceptin (trastuzumab, Roche AG)-bas ...

BioWorld Today - Staff - 2012-05-07 00:00 - 0 comments - 0 attachments

Clinic roundup

E-Therapeutics plc , of Oxford, UK, said the Medicines and Healthcare products Regulatory Agency has allowed it to resume recruiting patients for its phase Ia trial of ETS2101 in solid tumors after a drug storage issue forced the company to halt recr ...

BioWorld Today - Staff - 2014-03-27 00:00 - 0 comments - 0 attachments